Ian E Alexander - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ian E Alexander

Showing results (121-130 of 131) with videos related to

Pageof 14

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2014

Intrahepatic activation of naive CD4+ T cells by liver-resident phagocytic cellsSzun S Tay, Yik Chun Wong, Ben Roediger, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2017

Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral SeroreactivityNicole K Paulk, Katja Pekrun, Erhua Zhu, et al.

Nature Genetics|June 20, 2017

Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genomeGrant J Logan, Allison P Dane, Claus V Hallwirth, et al.

Molecular Therapy. Methods & Clinical Development|June 4, 2020

Attenuation of Heparan Sulfate Proteoglycan Binding Enhances <i>In Vivo</i> Transduction of Human Primary Hepatocytes with AAV2Marti Cabanes-Creus, Adrian Westhaus, Renina Gale Navarro, et al.

Science Translational Medicine|September 10, 2020

Restoring the natural tropism of AAV2 vectors for human liverMarti Cabanes-Creus, Claus V Hallwirth, Adrian Westhaus, et al.

Nature Communications|March 15, 2024

Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluationMarti Cabanes-Creus, Sophia H Y Liao, Renina Gale Navarro, et al.

Molecular Therapy. Methods & Clinical Development|September 7, 2023

Development of new adeno-associated virus capsid variants for targeted gene delivery to human cardiomyocytesCindy Y Kok, Shinya Tsurusaki, Marti Cabanes-Creus, et al.

Journal of Inherited Metabolic Disease|April 7, 2012

Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgiaCaroline Michot, Laurence Hubert, Norma B Romero, et al.

Human Gene Therapy|March 17, 2023

Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus VectorsAdrian Westhaus, Marti Cabanes-Creus, Kimberley L Dilworth, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|July 9, 2024

Sleeping Beauty mRNA-LNP enables stable rAAV transgene expression in mouse and NHP hepatocytes and improves vector potencyPhilip M Zakas, Sharon C Cunningham, Ann Doherty, et al.

Pageof 14

Search research articles

Showing results (121-130 of 131) with videos related to

Sort By:

Pageof 14

Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2014

Intrahepatic activation of naive CD4+ T cells by liver-resident phagocytic cellsSzun S Tay, Yik Chun Wong, Ben Roediger, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2017

Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral SeroreactivityNicole K Paulk, Katja Pekrun, Erhua Zhu, et al.

Nature Genetics|June 20, 2017

Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genomeGrant J Logan, Allison P Dane, Claus V Hallwirth, et al.

Molecular Therapy. Methods & Clinical Development|June 4, 2020

Attenuation of Heparan Sulfate Proteoglycan Binding Enhances <i>In Vivo</i> Transduction of Human Primary Hepatocytes with AAV2Marti Cabanes-Creus, Adrian Westhaus, Renina Gale Navarro, et al.

Science Translational Medicine|September 10, 2020

Restoring the natural tropism of AAV2 vectors for human liverMarti Cabanes-Creus, Claus V Hallwirth, Adrian Westhaus, et al.

Nature Communications|March 15, 2024

Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluationMarti Cabanes-Creus, Sophia H Y Liao, Renina Gale Navarro, et al.

Molecular Therapy. Methods & Clinical Development|September 7, 2023

Development of new adeno-associated virus capsid variants for targeted gene delivery to human cardiomyocytesCindy Y Kok, Shinya Tsurusaki, Marti Cabanes-Creus, et al.

Journal of Inherited Metabolic Disease|April 7, 2012

Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgiaCaroline Michot, Laurence Hubert, Norma B Romero, et al.

Human Gene Therapy|March 17, 2023

Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus VectorsAdrian Westhaus, Marti Cabanes-Creus, Kimberley L Dilworth, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|July 9, 2024

Sleeping Beauty mRNA-LNP enables stable rAAV transgene expression in mouse and NHP hepatocytes and improves vector potencyPhilip M Zakas, Sharon C Cunningham, Ann Doherty, et al.

Pageof 14